SAEs · participants with obesity
The review found no eligible studies for this question.
1 finding from 1 review
Reoperation rate · participants with obesity
1 finding from 1 review
Body‐mass index (BMI) · participants with obesity
1 finding from 1 review
Health related quality of life the Uniscale and the Symptom Distress Scale (SDS); Better indicated by lower values · participants with obesity
1 finding from 1 review
Comorbidities: diabetes · participants with obesity
1 finding from 1 review
Dentist-reported organoleptic test (OLT) score (scale 0 to 5) · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological…
It is very uncertain whether dual zinc + arginine dentifrice changes dentist-reported OLT hedonic rating (scale 1 to 9) compared with control (regular fluoride) dentifrice (very low certainty).
1 finding from 1 review
Oral candidiasis (present) · Patients with cancer receiving chemotherapy and/or radiotherapy
Norfloxacin plus amphotericin B showed no clear difference in oral candidiasis (present) compared with amphotericin B; GRADE not reported.
1 finding from 1 review
Systemic fungal infection · Patients with cancer receiving chemotherapy and/or radiotherapy
Norfloxacin plus amphotericin B showed no clear difference in systemic fungal infection compared with amphotericin B; GRADE not reported.
1 finding from 1 review
Clinical success (absence of periapical pathology, tenderness to pressure and fistula formation) at 24 months · adults with HIV and progressive disseminated histoplasmosis
Induction: liposomal amphotericin may leads to higher clinical success compared with amphotericin deoxycholate (low certainty).
1 finding from 1 review
Death · adults with HIV and progressive disseminated histoplasmosis
Induction: liposomal amphotericin showed no clear difference in death compared with amphotericin deoxycholate (low certainty).
1 finding from 1 review
Nephrotoxicity (safety population) · adults with HIV and progressive disseminated histoplasmosis
Induction: liposomal amphotericin leads to lower safety outcomes: nephrotoxicity compared with amphotericin deoxycholate (high certainty).
1 finding from 1 review
Safety outcomes: drug discontinuation · adults with HIV and progressive disseminated histoplasmosis
It is very uncertain whether induction: liposomal amphotericin changes safety outcomes: drug discontinuation compared with amphotericin deoxycholate (very low certainty).
1 finding from 1 review
Number of women cured · women with urinary incontinence
It is very uncertain whether PFMT added to electrical stimulation changes number of women cured compared with electrical stimulation alone (excluding implanted electrodes) (very low certainty).
1 finding from 1 review
Number of women reporting incontinence at 1 year or more after treatment (subjective) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Objective measure of urine leakage (e.g. pad test) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women experiencing pain ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease‐specific quality of life · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
General health status evaluation e.g. Short Form (SF)‐36 ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people with acute UGIH
It is very uncertain whether erythromycin plus nasogastric tube lavage changes all‐cause mortality compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).
1 finding from 1 review